C.M. Bidwell & Associates’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
LCM
BCC
MFP
SSP
C.M. Bidwell & Associates's ATEX Position: Q3 2020 in Review
C.M. Bidwell & Associates sold out of Anterix (ATEX) in Q3 2020, closing a stake of 600 shares — an estimated $27K sold.
C.M. Bidwell & Associates first reported a position in ATEX in Q2 2019 and held it in 5 quarters. The position peaked at $111K in Q2 2019. 96 funds tracked by Wall St. Rank hold ATEX as of Q3 2020.
- C.M. Bidwell & Associates reported no remaining Anterix position as of Q3 2020 after selling out during the quarter.
- C.M. Bidwell & Associates sold 600 Anterix shares in Q3 2020, an estimated $27K.
- C.M. Bidwell & Associates first reported a position in Anterix in Q2 2019 and held it in 5 quarters.
- C.M. Bidwell & Associates's Anterix position peaked at $111K in Q2 2019.
- 96 funds tracked by Wall St. Rank held Anterix as of Q3 2020.
Based on C.M. Bidwell & Associates's 13F filing for Q3 2020, filed 13 Nov 2020.